XTalks

OCTOBER 25, 2024

Shields Health Solutions, a specialty pharmacy owned by Walgreens, has partnered with Sutter Health to expand access to specialty medications across the US. This collaboration aims to support patients with chronic and complex conditions, particularly in oncology, rheumatology and dermatology.

Pharmacy 105

Pharmacy Dermatology Cardiology Drugs 105

XTalks

NOVEMBER 7, 2024

Maraoui said the company’s dermatology-focused sales force is “now preparing for a successful launch and to establish Emrosi as a new standard of care in the treatment of rosacea.” Journey Medical plans to make Emrosi available by early 2025 through dermatology clinics and pharmacies across the US.

FDA Approval 105

FDA Approval Dermatology Bacteria Clinical Trials 105

XTalks

AUGUST 2, 2023

Verrica Pharmaceuticals is a dermatology therapeutics company developing medications for skin diseases that require medical interventions. Tune into this episode to learn more about YCANTH and its approval, as well as the changing landscape of dermatology, from Dr. Eichenfield.

Life Science 52

Life Science FDA Approval Dermatology Pharmacy 52

XTalks

NOVEMBER 2, 2023

The biosimilar to Johnson & Johnson’s Stelara is approved for use by adults for the listed indications, as well as pediatric patients six years of age and older for the dermatologic indications (plaque psoriasis and psoriatic arthritis).

FDA Approval 59

FDA Approval Production Dermatology Sales 59